Abstract
Background
Familial adenomatous polyposis (FAP) has been divided into two entities: classical (CFAP) and attenuated (AFAP). With the discovery of MYH associated polyposis (MAP) syndrome, the clinical differences have become unclear. The aim of our study was to investigate patients with polyposis treated in our institution for a correlation between genotype and phenotype.
Methods
Between 1978 and 2007, 515 patients were followed. Four groups were identified: AFAP, CFAP, MAP, and no-mutation patients. Clinical, surgical, histological, and genetic data of patients were collected and compared. Two ranges of mutations responsible for AFAP were used.
Results
Patient breakdown was CFAP patients (n = 322/294), AFAP patients (n = 13/41), MYH patients (n = 17) and no-mut patients (n = 32). Patients not tested for APC mutation (n = 131) were excluded. Genotype/phenotype evaluation showed no difference in the number or location of polyps, age at colectomy, presence of cancer, or duodenal polyps. Major differences were found for MYH patients: later age at diagnosis, more cancers, fewer polyps, and more located in the right part of the colon. For phenotype/genotype correlation, patients aged more than 35 years at the time of colectomy and with fewer than 100 polyps had significantly more mutation found on MYH.
Conclusions
This two-way analysis did not show any correlation that might help to identify a subgroup of patients with APC mutation that may be considered attenuated. It is more likely that the MAP syndrome is the real AFAP.
Similar content being viewed by others
References
Bouvier AM, Remontet L, Jougla E, Launoy G, Grosclaude P, Buémi A, et al. Incidence of gastrointestinal cancers in France. Gastroenterol Clin Biol. 2004;28:877–81.
Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin. 1999;49:8–31.
Grady WM. Genetic testing for high-risk colon cancer patient. Gastroenterology. 2003;124:1574–94.
Benamouzig R, Chaussade S, Olschwang S. Polyposis coli: a practical approach. Gastroenterol Clin Biol. 2005;29:1035–9.
Penna CP, Tiret E, Kartheuser AH, Olschwang S, Parc R. Value of screening of familial adenomatous polyposis for prevention of colorectal cancer. Gastroenterol Clin Biol. 1992;16:210–4.
Lynch HT, Smyrk T, McGinn T, Lanspa S, Cavalieri J, Lynch J, et al. Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP. Cancer. 1995;76:2427–33.
Nieuwenhuis MH, Vasen HFA. Correlations between mutation site in APC and phenotype of familial adenomatous polyposes (FAP): A review of the literature. Crit Rev Oncol/Hematol. 2007;61:153–61.
Scott RJ, Meldrum C, Crooks R, Spigelman AD, Kirk J, Tucker K, et al. Familial adenomatous polyposis: more evidence for disease diversity and genetic heterogeneity. Gut. 2001;48:508–14.
Knudsen AL, Bisgaard ML, Bulow S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer. 2003;2:43–55.
Beroud C, Soussi T. APC gene: database of germline and somatic mutation in human tumors and cell lines. Nucl Acids Res. 1996;24:121–4.
Spirio L, Olschwang S, Groden J, Robertson M, Samowitz W, Joslyn G, et al. Alleles of the APC gene: an attenuated form of familial polyposis. Cell. 1993;75:951–7.
Gebert JF, Dupon C, Kadmon M, Hahn M, Herfarth C, von Knebel Doeberitz M, et al. Combined molecular and clinical approaches for the identification of families with familial adenomatous polyposis coli. Ann Surg. 1999;229:350–61.
Van der Luitj RB, Vassen HF, Tops CM, Breukel C, Fodde R, Meera Khan P. APC mutation in the alternatively spliced region of exon 9 associated with late onset of adenomatous polyposis. Hum Genet. 1995;96:705–10.
Burt RW, Leppert MF, Slattery ML, Samowitz WS, Spirio LN, Kerber RA, et al. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology. 2004;127:444–51.
Lipton L, Tomlinson I. The genetics of FAP and FAP-like syndromes. Fam Cancer. 2006;5:221–6.
Moisio AL, Järvinen H, Peltomäki P. Genetic and clinical characterisation of familial adenomatous polyposis: a population based study. Gut. 2002;50:845–50.
Vasen HF, van der Luijt RB, Slors JF, Buskens E, de Ruiter P, Baeten CG, et al. Molecular genetic tests as a guide to surgical management of familial adenomatous polyposes. Lancet. 1996;348:433–5.
Wu JS, Paul P, McGannon EA, Church JM. APC genotype, polyp number, and surgical options in familial adenomatous polyposis. Ann Surg. 1998;227:57–62.
Bülow C, Vasen H, Järvinen H, Björk J, Bisgaard ML, Bülow S. Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposes. Gastroenterology. 2000;119:1454–60.
Friedl W, Caspari R, Sengteller M, Uhlhaas S, Lamberti C, Jungck M, et al. Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposes? Experience from 680 FAP families. Gut. 2001;48:515–21.
Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, et al. Inherited variants of MYH associated with somatic G:C → T:A mutations in colorectal tumors. Nat Genet. 2002;30:227–32.
Sieber OM, Lipton L, Crabtree M, Heinimann K, Fidalgo P, Phillips RK, et al. Multiple colorectal adenomas, classic adenomatous polyposis and germ-line mutations in MYH. N Engl J Med. 2003;348:791–9.
Lefevre JH, Rodrigue CM, Mourra N, Bennis M, Flejou JF, Parc R, et al. Implication of MYH in colorectal polyposis. Ann Surg. 2006;244:874–80.
Bussey HJR. Familial Polyposis Coli. Baltimore: John Hopkins Univeristy Press 1975.
Johns LE, Houslton RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001;96:2292–3003.
Caspari R, Olschwang S, Friedl W, Mandl M, Boisson C, Böker T, et al. Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet. 1995;4:337–40.
Houlston R, Crabtree M, Phillips R, Crabtree M, Tomlinson I. Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genes. Gut. 2001;48:1–5.
Matsuo S, Eguchi S, Azuma T, Hidaka M, Yamaguchi S, Hayashi T, et al. Attenuated familial adenomatous polyposis associated with advanced rectal cancer in a 16-year-old boy: report of a case. Surg Today. 2001;31:1020–3.
Giardiello FM, Krush AJ, Petersen GM, Booker SV, Kerr M, Tong LL, et al. Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology. 1994;106:1542–7.
Sieber OM, Segditsas S, Knudsen AL, Zhang J, Luz J, Rowan AJ, et al. Disease severity and genetic pathways in attenuated familial polyposis vary greatly but depend on the site of the germline mutation. Gut. 2006;55:1440–8.
Lamlum H, Al Tassan N, Jaeger E, Frayling I, Sieber O, Reza FB, et al. Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. Hum Mol Genet. 2000;9:2215–21.
Sieber OM, Lamlum H, Crabtree MD, Rowan AJ, Barclay E, Lipton L, et al. Whole gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or multiple colorectal adenomas. Proc Natl Acad Sci USA. 2000;99:2954–8.
Nilbert M, Fernebro J, Kristofferson U. Novel germline APC mutations in Swedish patients with familial adenomatous polyposis and Gardner syndrome. Scand J Gastroenterol. 2000;35:1200–3.
Acknowledgment
There are no potential conflicts of interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lefevre, J.H., Parc, Y., Svrcek, M. et al. APC, MYH, and the Correlation Genotype-Phenotype in Colorectal Polyposis. Ann Surg Oncol 16, 871–877 (2009). https://doi.org/10.1245/s10434-008-0297-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-008-0297-0